RAPT Therapeutics Inc.

1.22
0.03 (2.52%)
At close: Jan 17, 2025, 3:59 PM
1.20
-1.23%
After-hours Jan 17, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -116.80M -83.84M -69.20M -52.89M -43.00M -36.15M -29.11M
Depreciation & Amortization 1.22M 1.05M 996.00K 1.12M 1.33M 1.24M 1.38M
Stock-Based Compensation 17.09M 11.26M 9.95M 8.69M 2.05M 1.17M 716.00K
Other Working Capital -1.84M -5.04M -5.23M -46.00K 3.40M -691.00K -34.00K
Other Non-Cash Items -4.06M 2.09M 1.53M 248.00K 20.00K -14.00K -9.00K
Deferred Income Tax n/a n/a n/a n/a -11.00K 17.00K 15.00K
Change in Working Capital 5.50M -1.33M -4.30M 2.34M 4.13M 784.00K -114.00K
Operating Cash Flow -97.05M -70.77M -61.03M -40.49M -35.47M -32.95M -27.12M
Capital Expenditures -1.13M -845.00K -755.00K -398.00K -888.00K -3.50M -1.12M
Acquisitions n/a 44.65M 80.59M 87.04M 45.00K n/a n/a
Purchase of Investments -161.50M -190.86M -164.98M -139.33M n/a n/a n/a
Sales Maturities Of Investments 266.75M 146.21M 84.39M 52.30M n/a n/a n/a
Other Investing Acitivies n/a -44.65M -80.59M -87.04M 45.00K n/a n/a
Investing Cash Flow 104.13M -45.49M -81.35M -87.44M -843.00K -3.50M -1.12M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 1.45M 1.39M 2.02M 1.85M 14.38M 105.20M 59.96M
Financial Cash Flow 1.45M 131.18M 141.48M 75.46M 49.90M 52.73M 30.10M
Net Cash Flow 8.53M 14.92M -891.00K -52.47M 13.59M 16.28M 1.85M
Free Cash Flow -98.17M -71.62M -61.78M -40.89M -36.36M -36.45M -28.25M

Create Price Alert on RAPT

Your price alert will notify you when the stock price is above 1.22.

Add to Watchlist